IHEvsTMEDETF Comparison
VS
iShares U.S. Pharmaceuticals ETF (IHE) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. IHE's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, TMED's top sector exposures are Healthcare and Consumer Non-Cyclicals.Non-Corporate, IHE is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.44% for TMED. IHE is up 21% year-to-date (YTD) with +$434M in YTD flows. TMED performs worse with 13.93% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of IHE and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IHE vs TMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE TMED | +8.25%+5.49% | +17.70%+10.90% | +21.00%+13.93% | +49.98%+37.87% | +76.25%n/a | +74.85%n/a |
| Flows | IHE TMED | +$399M+$2M | +$357M+$2M | +$434M+$5M | +$588M+$9M | +$682M- | +$698M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE TMED | +21.33%+18.84% | +18.06%+18.33% | +16.91%n/a | +16.50%n/a |
| Max drawdown | IHE TMED | -4.42%-4.40% | -8.48%-11.09% | -16.04%n/a | -16.12%n/a |
| Max drawdown duration | IHE TMED | 16d15d | 81d125d | 210dn/a | 669dn/a |
Trading data
IHE | TMED | |
Last sale 7/24/2026 at 6:08 PM | $102.41 | $34.34 |
| Previous close 07/23/2026 | $101.99 | $34.23 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
TMED
is actively managed and doesn’t replicate an indexIHE | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 6:08 PM
Live
Closed
IHE | TMED | |
|---|---|---|
| Last price | $102.41 | $34.34 |
| 1D performance | +0.41% | +0.33% |
| AuM | $1.47 B | $24.52 M |
| E/R | 0.38% | 0.44% |
Characteristics
IHE | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | T. Rowe Price |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | - |
| N° of holdings | 57 | 95 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | June 11, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
IHE
USA
96.01%
Other
3.99%
TMED
USA
93.24%
Other
6.76%
Sectors
IHE
Healthcare
99.92%
Other
0.08%
TMED
Healthcare
97.94%
Other
2.06%
Advertisement
Diversification
IHE
Total weight of top 15 holdings out of 15
84.53%
TMED
Total weight of top 15 holdings out of 15
57.45%
Top 15 holdings
Data as of June 30, 2026
IHE
Johnson & Johnson
22.44%
Eli Lilly & Co.
22.25%
Merck & Co., Inc.
4.55%
Bristol Myers Squibb Co.
4.37%
Royalty Pharma Plc
4.33%
Viatris, Inc.
4.22%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.73%
Jazz Pharmaceuticals Plc
3.45%
Elanco Animal Health, Inc.
2.81%
Axsome Therapeutics, Inc.
2.41%
Corcept Therapeutics, Inc.
1.90%
Ligand Pharmaceuticals, Inc.
1.45%
Definium Therapeutics, Inc.
1.39%
Liquidia Corp.
1.28%
TMED
Eli Lilly & Co.
16.59%
UnitedHealth Group, Inc.
6.52%
Gilead Sciences, Inc.
4.55%
Thermo Fisher Scientific, Inc.
4.11%
Danaher Corp.
2.96%
Cencora, Inc.
2.82%
Agilent Technologies, Inc.
2.61%
Alnylam Pharmaceuticals, Inc.
2.60%
Intuitive Surgical, Inc.
2.55%
Insulet Corp.
2.38%
Stryker Corp.
2.22%
Dyne Therapeutics, Inc.
2.03%
Elanco Animal Health, Inc.
1.91%
Pfizer Inc.
1.91%
Waters Corp.
1.68%
Frequently asked questions about IHE and TMED
How have the IHE and TMED ETFs performed in 2026?
As of July 23, 2026, IHE is up 21% year-to-date (YTD), while TMED has returned 13.93%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: IHE or TMED?
Year-to-date, the IHE ETF saw +$434M in flows, compared to +$5M for TMED.
Which ETF is more volatile: IHE or TMED?
Over the past year, IHE had a volatility of 18.06%, while TMED experienced 18.33%.
Which ETF is bigger: IHE or TMED?
As of July 23, 2026, IHE holds $1.47 B in assets under management (AUM), while TMED manages $24.52 M.
What sectors do the IHE and TMED ETFs invest in?
IHE leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.
What are the top holdings of the IHE ETF and TMED ETF?
IHE top holdings include Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc.. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Gilead Sciences, Inc..
Which ETF is more diversified: IHE or TMED?
IHE holds 57 securities with 84.53% of its assets in the top 15. TMED has 95 securities and a top 15 weight of 57.45%.
Advertisement
Latest news about IHE & TMED
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
